CMDL’s pharmacological testing services support precision medicine by analysing how
individual genetic variations influence drug metabolism, efficacy, and safety. Using
advanced molecular techniques, we assess key pharmacogenetic markers to guide
optimal drug selection and dosing for conditions such as cardiovascular disease, cancer,
infectious diseases, and psychiatric disorders. This approach reduces adverse drug
reactions, enhances treatment efficacy, and minimises trial-and-error prescribing. Our
testing portfolio includes evaluation of genes affecting drug-metabolising enzymes, CMDL’s pharmacological testing services support precision medicine by analysing how
individual genetic variations influence drug metabolism, efficacy, and safety. Using
advanced molecular techniques, we assess key pharmacogenetic markers to guide
optimal drug selection and dosing for conditions such as cardiovascular disease, cancer,
infectious diseases, and psychiatric disorders. This approach reduces adverse drug
reactions, enhances treatment efficacy, and minimises trial-and-error prescribing. Our
testing portfolio includes evaluation of genes affecting drug-metabolising enzymes,
